CDC Entreprises, a subsidiary of Caisse des Dépôts and a future bpifrance1 entity, has been mandated by the French government to manage the FNA as part of the Investing in the Future Programme (Programme d’Investissements d’Avenir). It is collaborating with AFM-Téléthon (French muscular dystrophy association organising French Téléthon), an association of patients and parents of patients, to help introduce new biotherapies and provide access to groundbreaking treatments for people with rare diseases. The partners are announcing that a new €50 million fund has been set up and will be overseen by CDC Entreprises.
